Contract Research Organization, CRO, PrimeVigilance, is significantly enhancing its service offerings with Oracle (ORCL) Argus. Delivering the full lifecycle of pharmacovigilance services, the CRO is leveraging Argus to provide its clients with a powerful, AI-driven solution to help optimize their drug development programs and support patient safety and regulatory compliance. PrimeVigilance is part of the Ergomed Group whose mission is to deliver leading solutions that support its customers’ clinical projects to speed the development of new drugs.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
- Oracle price target raised to $268 from $225 at Bernstein
- Oracle’s Strong Growth Potential and Strategic Positioning Drive Buy Rating
- C3 AI would ‘fit nicely’ with Oracle’s software, Barron’s reports
- Oracle (ORCL) Lures U.S. Government with Huge Discounts on Software and Cloud
- Oracle gives U.S. federal government discount on cloud, software, WSJ says